SP
BravenNow
Duchenne muscular dystrophy
🌐 Entity

Duchenne muscular dystrophy

Type of muscular dystrophy

πŸ“Š Rating

1 news mentions Β· πŸ‘ 0 likes Β· πŸ‘Ž 0 dislikes

πŸ“Œ Topics

  • Stock Market Analysis (1)
  • Biotechnology Clinical Trials (1)
  • Investment Outlook (1)

🏷️ Keywords

Guggenheim (1) Β· PepGen (1) Β· Stock Price Target (1) Β· Clinical Trials (1) Β· Biotechnology (1) Β· Pharmaceutical Investments (1) Β· PepFect Technology (1) Β· Neurological Disorders (1)

πŸ“– Key Information

Duchenne muscular dystrophy (DMD) is a severe type of muscular dystrophy predominantly affecting boys. The onset of muscle weakness typically begins around age four, with rapid progression. Initially, muscle loss occurs in the thighs and pelvis, extending to the arms, which can lead to difficulties in standing up.

πŸ“° Related News (1)

πŸ”— Entity Intersection Graph

Clinical trial(1)Biotechnology(1)Guggenheim(1)Duchenne muscular dystrophy

People and organizations frequently mentioned alongside Duchenne muscular dystrophy:

πŸ”— External Links